GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectorite Biomedical Inc (ROCO:4170) » Definitions » Days Sales Outstanding

Vectorite Biomedical (ROCO:4170) Days Sales Outstanding : 30.00 (As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is Vectorite Biomedical Days Sales Outstanding?

Vectorite Biomedical's average Accounts Receivable for the six months ended in Dec. 2023 was NT$4.91 Mil. Vectorite Biomedical's Revenue for the six months ended in Dec. 2023 was NT$29.87 Mil. Hence, Vectorite Biomedical's Days Sales Outstanding for the six months ended in Dec. 2023 was 30.00.

The historical rank and industry rank for Vectorite Biomedical's Days Sales Outstanding or its related term are showing as below:

ROCO:4170' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.41   Med: 32.58   Max: 303.47
Current: 33.56

During the past 12 years, Vectorite Biomedical's highest Days Sales Outstanding was 303.47. The lowest was 4.41. And the median was 32.58.

ROCO:4170's Days Sales Outstanding is ranked better than
83% of 888 companies
in the Biotechnology industry
Industry Median: 72.34 vs ROCO:4170: 33.56

Vectorite Biomedical's Days Sales Outstanding declined from Dec. 2022 (37.90) to Dec. 2023 (30.00).


Vectorite Biomedical Days Sales Outstanding Historical Data

The historical data trend for Vectorite Biomedical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectorite Biomedical Days Sales Outstanding Chart

Vectorite Biomedical Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.41 20.26 18.29 28.47 36.68

Vectorite Biomedical Semi-Annual Data
Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec21 Jun22 Dec22 Jun23 Dec23
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 12.62 37.90 34.31 30.00

Competitive Comparison of Vectorite Biomedical's Days Sales Outstanding

For the Biotechnology subindustry, Vectorite Biomedical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vectorite Biomedical's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vectorite Biomedical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Vectorite Biomedical's Days Sales Outstanding falls into.



Vectorite Biomedical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Vectorite Biomedical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (5.588 + 5.637) / 2 ) / 55.853*365
=5.6125 / 55.853*365
=36.68

Vectorite Biomedical's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding (Q: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2023 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (4.183 + 5.637) / 2 ) / 29.869*365 / 2
=4.91 / 29.869*365 / 2
=30.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vectorite Biomedical  (ROCO:4170) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Vectorite Biomedical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Vectorite Biomedical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectorite Biomedical (ROCO:4170) Business Description

Traded in Other Exchanges
N/A
Address
Xintai 5th Road, 6th Floor, Number 97, Section 1, Yuzhi District, New Taipei City, Taipei, TWN, 22175
Vectorite Biomedical Inc is a Taiwan-based diagnostic and research company. It prepares studies of adult healthy cells, cell preparation and application.

Vectorite Biomedical (ROCO:4170) Headlines

No Headlines